Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018

• 主要な著者: Edwina Wright (著者), Andrew Grulich (著者), Katy Roy (著者), Mark Boyd (著者), Vincent Cornelisse (著者), Darren Russell (著者), Darryl O'Donnell (著者), Bill Whittaker (著者), Levinia Crooks (著者), Iryna Zablotska (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2018-07-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Daily use of coformulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. These 2017 Australasian Society for H...